# Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia

Study · id `cardio:ct-nct01791543` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01791543](<https://clinicaltrials.gov/study/NCT01791543>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01791543

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

## Technical summary

Registry record NCT01791543. Allocation not applicable; no masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2022-05-27 (actual). Results posted on 2023-02-01.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 115 participants (enrolled count; ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Started: 2016-09 (actual) (ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Primary completion: 2022-05-27 (actual) (ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Completion: 2022-05-27 (actual) (ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Results first posted: 2023-02-01 (ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01791543, source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01791543-2023-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
- Condition: Ventricular Tachycardia
- Intervention (Device): Intramural Needle Ablation Catheter
- Lead sponsor: William Stevenson
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)

## Provenance

Content hash: cd2dd9553e5be9a37c476fbc10277c0b634fd0930fdfbb58979d4dbbfcfe43f5
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
